Description
The overall goal of this project is to advance the clinical development of Poly-ICLC (Hiltonol®), a broad-spectrum antiviral drug candidate, as an innovative solution to strengthen medical preparedness against viral threats.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02021-03-18$2,099,792
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2021-03-18(start date) | $2,099,792 | — | The overall goal of this project is to advance the clinical development of Poly-ICLC (Hiltonol®), a broad-spec… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other recipients funded under "Innovation for Defence Excellence and Security Program" by National Defence | Défense nationale (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 018-2026-2027-Q1-06-MN5-019 | École de technologie supérieure | FY2027 | $999,900 | FY2027 |
| 018-2026-2027-Q1-06-MN5-036 | École Polytechnique De Montréal | FY2027 | $997,600 | FY2027 |
| 018-2026-2027-Q1-06-MN5-045 | University of Victoria | Université de Victoria | FY2027 | $979,455 | FY2027 |
| 018-2026-2027-Q1-06-MN5-014 | University of Calgary | l'Université de Calgary | FY2027 | $1,000,000 | FY2027 |
| 018-2026-2027-Q1-06-MN5-022 | University of Waterloo | Université de Waterloo | FY2027 | $684,250 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 032-2020-2021-Q4-00010 · retrieved 2026-11-15.